Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,110 public trials 619 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Clinical Study of WT2725 in Patients With Advanced Malignancies

NCT01621542

Conditions
Cancer, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +20 more
Locations
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
  • Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States
View Trial Details
Completed

Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML)

NCT02447666

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • St. Anna Kinderkrebsforschung, CHILDREN'S CANCER RESEARCH INSTITUTE Vienna, Austria
  • Hopital Universitaire des Enfants Brussels, Belgium
  • University Hospital Ghent Ghent, Belgium
  • University Hospital Motol Prague, Czechia
View all 39 locations
View Trial Details
Completed

A Study of Active Immunotherapy With GRNVAC1 in Patients With Acute Myelogenous Leukemia (AML)

NCT00510133

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Loyola University Medical Center Maywood, Illinois, United States
  • Washington University School of Medicine, Siteman Cancer Center St Louis, Missouri, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Completed

A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of Three Different Regimens; (1) High-Dose Lenalidomide; (2) Lenalidomide + Azacitidine; or (3) Azacitidine in Subjects ≥ 65 Years With Newly-Diagnosed Acute Myeloid Leukemia

NCT01358734

Conditions
Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +6 more
Locations
  • (210) University of Arizona Cancer Center Tucson, Arizona, United States
  • (180) University of California, San Diego La Jolla, California, United States
  • (240) Cedars-Sinai Medical Center Los Angeles, California, United States
  • (215) Hematology Oncology Medical Group Orange, California, United States
View all 30 locations
View Trial Details
Completed

Dose-escalation Study of Oral Administration of S 055746 in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome

NCT02920541

Conditions
Acute Myeloid Leukaemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • The Alfred Hospital Melbourne, Australia
  • Royal Melbourne Hospital Parkville, Australia
  • Institut Paoli Calmettes Marseille, France
  • Hôpital Saint Louis Paris, France
View Trial Details
Completed

Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML

NCT00895934

Conditions
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +26 more
Locations
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • Harrison HealthPartners Hematology and Oncology-Bremerton Bremerton, Washington, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • University of Washington Medical Center Seattle, Washington, United States
View Trial Details

Related conditions